Back

Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings

Discover AI Stocks Potentially Ready to Skyrocket in Value!

Act fast! Secure your FREE report now. Click Here!

Buy

APLS
Apellis Pharmaceuticals

Last Price:

62.78

Seasonality Move:

20.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street Insider Makes Prediction about Hot A.I. Stock

Learn more here.

Apellis Pharmaceuticals Price Quote

$62.78

+0.05 (+-1.97%)

(Updated: December 9, 2023 at 8:44 AM ET)

Apellis Pharmaceuticals Key Stats

Buy

Apellis Pharmaceuticals (APLS) is a Buy

Day range:

$61.35 - $63.50

52-week range:

$19.83 - $94.75

Dividend yield:

P/E ratio:

0.00

P/S ratio:

26.67

P/B ratio:

32%

Volume:

1.6M

Avg. volume:

1-year change:

24.56%

Market cap:

$7.4B

Revenue:

$75.4M

EPS:

$-5.25

How Much Does Apellis Pharmaceuticals Make?

How Much Are Apellis Pharmaceuticals's Sales Annually?
APLS Revenues are $75.4M
How Much Profit Does Apellis Pharmaceuticals's Make A Year?
APLS net income is -$652.2M

Is Apellis Pharmaceuticals Growing As A Company?

What Is Apellis Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 4.01%
What Is Apellis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Apellis Pharmaceuticals Stock Price Performance

Did Apellis Pharmaceuticals Stock Go Up Last Month?
Apellis Pharmaceuticals share price went up by 33.5% last month
Did APLS's Share Price Rise Over The Last Year?
APLS share price rose by 24.56% over the past 1 year

What Is Apellis Pharmaceuticals 52-Week High & Low?

What Is Apellis Pharmaceuticals’s 52-Week High Share Price?
Apellis Pharmaceuticals has traded as high as $94.75 over the past 52 weeks
What Is Apellis Pharmaceuticals’s 52-Week Low Share Price?
Apellis Pharmaceuticals has traded as low as $19.83 over the past 52 weeks

Apellis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Apellis Pharmaceuticals?

How Much Debt Does Apellis Pharmaceuticals Have?
Total long term debt quarterly is $93M
How Much Cash Does Apellis Pharmaceuticals Have?
Cash and short term investments quarterly total is $452.4M
What Is Apellis Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.96

Is Apellis Pharmaceuticals Cash Flow Positive?

What Is APLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$637.6M
What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $382.5M
What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $123.5M

Apellis Pharmaceuticals Return On Invested Capital

Is Management Doing A Good Job?
APLS return on invested capital is -156.91%
What Is Apellis Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -69.73%
What Is APLS Return On Equity?
ROE is a measure of profitability and is -206.55%

Apellis Pharmaceuticals Earnings Date & Stock Price

What Is Apellis Pharmaceuticals's Stock Price Today?
A single share of APLS can be purchased today for 62.73
What Is Apellis Pharmaceuticals’s Stock Symbol?
Apellis Pharmaceuticals trades on the nasdaq under the ticker symbol: APLS
When Is Apellis Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Apellis Pharmaceuticals is scheduled on February 21, 2024
When Is APLS's next ex-dividend date?
Apellis Pharmaceuticals's next ex-dividend date is December 10, 2023
How To Buy Apellis Pharmaceuticals Stock?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Apellis Pharmaceuticals Competitors

Who Are Apellis Pharmaceuticals's Competitors?
Below is a list of companies who compete with Apellis Pharmaceuticals or are related in some way:
- Avid Bioservices Inc (CDMO)
- EyePoint Pharmaceuticals Inc (EYPT)
- Regeneron Pharmaceuticals Inc (REGN)
- TG Therapeutics Inc (TGTX)
- United Therapeutics Corp (UTHR)

Apellis Pharmaceuticals Dividend Yield